The finding that EpCAM aptamer-delivered PKCι siRNA selectively induces apoptosis in PRKCI-amplified ovarian cancer cells led us to further investigate the efficacy of EpCAM-siPKCι aptamer to suppress ovarian tumor progression. Here, PRKCI is linked to ovarian cancer.